Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...

Over the past year, many Cencora, Inc. (NYSE:COR) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is usually more ...

Cencora, Inc. (NYSE:COR – Get Free Report) has received an average recommendation of “Moderate Buy” from the eleven ratings firms that are covering the firm, Marketbeat Ratings reports.

Cencora, Inc. (NYSE:COR – Free Report) – Equities researchers at Leerink Partnrs lifted their Q3 2025 earnings estimates for Cencora in a research report issued on Wednesday, February 5th.

Over the past year, many Cencora, Inc. (NYSE:COR) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is usually more ...

Perhaps you’re on the verge of burnout and have been overwhelmed by the never-ending alterations of life. Or you find yourself floating between fear and focus, constantly feeling like you aren ...

In December, the Centers for Medicare and Medicaid Services released justifications for the maximum ... [+] fair prices it arrived in negotiations with drug makers for the first 10 medications ...

My approach is both directive and accepting. I am a client-centered therapist. I can help solve problems that can take years to resolve on their own by teaching new skills and giving homework to ...

Invesco Health Care Fund earns a Low Process Pillar rating. The main driver of the rating is the fund's unimpressive long-term risk-adjusted performance. This can be seen in its five-year alpha ...